<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2002-03-27" modified="2017-05-10" version="176">
<accession>Q9UM73</accession>
<accession>Q4ZFX9</accession>
<accession>Q53QQ6</accession>
<accession>Q53RZ4</accession>
<accession>Q59FI3</accession>
<accession>Q9Y4K6</accession>
<name>ALK_HUMAN</name>
<protein>
<recommendedName>
<fullName>ALK tyrosine kinase receptor</fullName>
<ecNumber>2.7.10.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Anaplastic lymphoma kinase</fullName>
</alternativeName>
<cdAntigenName>CD246</cdAntigenName>
</protein>
<gene>
<name type="primary">ALK</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1997" name="Oncogene" volume="14" first="2175" last="2188">
<title>ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK).</title>
<authorList>
<person name="Morris S.W."/>
<person name="Naeve C.W."/>
<person name="Mathew P."/>
<person name="James P.L."/>
<person name="Kirstein M.N."/>
<person name="Cui X."/>
<person name="Witte D.P."/>
</authorList>
<dbReference type="PubMed" id="9174053"/>
<dbReference type="DOI" id="10.1038/sj.onc.1201062"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>GLYCOSYLATION</scope>
<scope>VARIANT VAL-1461</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1997" name="Oncogene" volume="15" first="2883" last="2883">
<authorList>
<person name="Morris S.W."/>
<person name="Naeve C.W."/>
<person name="Mathew P."/>
<person name="James P.L."/>
<person name="Kirstein M.N."/>
<person name="Cui X."/>
<person name="Witte D.P."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1997" name="Oncogene" volume="14" first="439" last="449">
<title>Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system.</title>
<authorList>
<person name="Iwahara T."/>
<person name="Fujimoto J."/>
<person name="Wen D."/>
<person name="Cupples R."/>
<person name="Bucay N."/>
<person name="Arakawa T."/>
<person name="Mori S."/>
<person name="Ratzkin B."/>
<person name="Yamamoto T."/>
</authorList>
<dbReference type="PubMed" id="9053841"/>
<dbReference type="DOI" id="10.1038/sj.onc.1200849"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANTS VAL-1461; ARG-1491 AND GLU-1529</scope>
</reference>
<reference key="4">
<citation type="submission" date="2005-03" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Takeda T."/>
<person name="Sakaki Y."/>
<person name="Tanaka A."/>
<person name="Yokoyama S."/>
<person name="Ohara O."/>
<person name="Nagase T."/>
<person name="Kikuno R.F."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANTS VAL-1461; ARG-1491 AND GLU-1529</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2005" name="Nature" volume="434" first="724" last="731">
<title>Generation and annotation of the DNA sequences of human chromosomes 2 and 4.</title>
<authorList>
<person name="Hillier L.W."/>
<person name="Graves T.A."/>
<person name="Fulton R.S."/>
<person name="Fulton L.A."/>
<person name="Pepin K.H."/>
<person name="Minx P."/>
<person name="Wagner-McPherson C."/>
<person name="Layman D."/>
<person name="Wylie K."/>
<person name="Sekhon M."/>
<person name="Becker M.C."/>
<person name="Fewell G.A."/>
<person name="Delehaunty K.D."/>
<person name="Miner T.L."/>
<person name="Nash W.E."/>
<person name="Kremitzki C."/>
<person name="Oddy L."/>
<person name="Du H."/>
<person name="Sun H."/>
<person name="Bradshaw-Cordum H."/>
<person name="Ali J."/>
<person name="Carter J."/>
<person name="Cordes M."/>
<person name="Harris A."/>
<person name="Isak A."/>
<person name="van Brunt A."/>
<person name="Nguyen C."/>
<person name="Du F."/>
<person name="Courtney L."/>
<person name="Kalicki J."/>
<person name="Ozersky P."/>
<person name="Abbott S."/>
<person name="Armstrong J."/>
<person name="Belter E.A."/>
<person name="Caruso L."/>
<person name="Cedroni M."/>
<person name="Cotton M."/>
<person name="Davidson T."/>
<person name="Desai A."/>
<person name="Elliott G."/>
<person name="Erb T."/>
<person name="Fronick C."/>
<person name="Gaige T."/>
<person name="Haakenson W."/>
<person name="Haglund K."/>
<person name="Holmes A."/>
<person name="Harkins R."/>
<person name="Kim K."/>
<person name="Kruchowski S.S."/>
<person name="Strong C.M."/>
<person name="Grewal N."/>
<person name="Goyea E."/>
<person name="Hou S."/>
<person name="Levy A."/>
<person name="Martinka S."/>
<person name="Mead K."/>
<person name="McLellan M.D."/>
<person name="Meyer R."/>
<person name="Randall-Maher J."/>
<person name="Tomlinson C."/>
<person name="Dauphin-Kohlberg S."/>
<person name="Kozlowicz-Reilly A."/>
<person name="Shah N."/>
<person name="Swearengen-Shahid S."/>
<person name="Snider J."/>
<person name="Strong J.T."/>
<person name="Thompson J."/>
<person name="Yoakum M."/>
<person name="Leonard S."/>
<person name="Pearman C."/>
<person name="Trani L."/>
<person name="Radionenko M."/>
<person name="Waligorski J.E."/>
<person name="Wang C."/>
<person name="Rock S.M."/>
<person name="Tin-Wollam A.-M."/>
<person name="Maupin R."/>
<person name="Latreille P."/>
<person name="Wendl M.C."/>
<person name="Yang S.-P."/>
<person name="Pohl C."/>
<person name="Wallis J.W."/>
<person name="Spieth J."/>
<person name="Bieri T.A."/>
<person name="Berkowicz N."/>
<person name="Nelson J.O."/>
<person name="Osborne J."/>
<person name="Ding L."/>
<person name="Meyer R."/>
<person name="Sabo A."/>
<person name="Shotland Y."/>
<person name="Sinha P."/>
<person name="Wohldmann P.E."/>
<person name="Cook L.L."/>
<person name="Hickenbotham M.T."/>
<person name="Eldred J."/>
<person name="Williams D."/>
<person name="Jones T.A."/>
<person name="She X."/>
<person name="Ciccarelli F.D."/>
<person name="Izaurralde E."/>
<person name="Taylor J."/>
<person name="Schmutz J."/>
<person name="Myers R.M."/>
<person name="Cox D.R."/>
<person name="Huang X."/>
<person name="McPherson J.D."/>
<person name="Mardis E.R."/>
<person name="Clifton S.W."/>
<person name="Warren W.C."/>
<person name="Chinwalla A.T."/>
<person name="Eddy S.R."/>
<person name="Marra M.A."/>
<person name="Ovcharenko I."/>
<person name="Furey T.S."/>
<person name="Miller W."/>
<person name="Eichler E.E."/>
<person name="Bork P."/>
<person name="Suyama M."/>
<person name="Torrents D."/>
<person name="Waterston R.H."/>
<person name="Wilson R.K."/>
</authorList>
<dbReference type="PubMed" id="15815621"/>
<dbReference type="DOI" id="10.1038/nature03466"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1994" name="Science" volume="263" first="1281" last="1284">
<title>Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.</title>
<authorList>
<person name="Morris S.W."/>
<person name="Kirstein M.N."/>
<person name="Valentine M.B."/>
<person name="Dittmer K.G."/>
<person name="Shapiro D.N."/>
<person name="Saltman D.L."/>
<person name="Look A.T."/>
</authorList>
<dbReference type="PubMed" id="8122112"/>
<dbReference type="DOI" id="10.1126/science.8122112"/>
</citation>
<scope>PARTIAL NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH NPM1</scope>
<scope>VARIANT VAL-1461</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2001" name="FASEB J." volume="15" first="1416" last="1418">
<title>The cytoplasmic truncated receptor tyrosine kinase ALK homodimer immortalizes and cooperates with ras in cellular transformation.</title>
<authorList>
<person name="Simonitsch I."/>
<person name="Polgar D."/>
<person name="Hajek M."/>
<person name="Duchek P."/>
<person name="Skrzypek B."/>
<person name="Fassl S."/>
<person name="Lamprecht A."/>
<person name="Schmidt G."/>
<person name="Krupitza G."/>
<person name="Cerni C."/>
</authorList>
<dbReference type="PubMed" id="11387242"/>
</citation>
<scope>FUNCTION AS AN ONCOGENE</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="9526" last="9531">
<title>Activation of anaplastic lymphoma kinase receptor tyrosine kinase induces neuronal differentiation through the mitogen-activated protein kinase pathway.</title>
<authorList>
<person name="Souttou B."/>
<person name="Carvalho N.B."/>
<person name="Raulais D."/>
<person name="Vigny M."/>
</authorList>
<dbReference type="PubMed" id="11121404"/>
<dbReference type="DOI" id="10.1074/jbc.M007333200"/>
</citation>
<scope>PHOSPHORYLATION</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="16772" last="16779">
<title>Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin.</title>
<authorList>
<person name="Stoica G.E."/>
<person name="Kuo A."/>
<person name="Aigner A."/>
<person name="Sunitha I."/>
<person name="Souttou B."/>
<person name="Malerczyk C."/>
<person name="Caughey D.J."/>
<person name="Wen D."/>
<person name="Karavanov A."/>
<person name="Riegel A.T."/>
<person name="Wellstein A."/>
</authorList>
<dbReference type="PubMed" id="11278720"/>
<dbReference type="DOI" id="10.1074/jbc.M010660200"/>
</citation>
<scope>INTERACTION WITH PTN</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2002" name="Genes Chromosomes Cancer" volume="34" first="354" last="362">
<title>Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor.</title>
<authorList>
<person name="Cools J."/>
<person name="Wlodarska I."/>
<person name="Somers R."/>
<person name="Mentens N."/>
<person name="Pedeutour F."/>
<person name="Maes B."/>
<person name="De Wolf-Peeters C."/>
<person name="Pauwels P."/>
<person name="Hagemeijer A."/>
<person name="Marynen P."/>
</authorList>
<dbReference type="PubMed" id="12112524"/>
<dbReference type="DOI" id="10.1002/gcc.10033"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH ALO17 AND CARS</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="14153" last="14158">
<title>Pleiotrophin signaling through anaplastic lymphoma kinase is rate-limiting for glioblastoma growth.</title>
<authorList>
<person name="Powers C."/>
<person name="Aigner A."/>
<person name="Stoica G.E."/>
<person name="McDonnell K."/>
<person name="Wellstein A."/>
</authorList>
<dbReference type="PubMed" id="11809760"/>
<dbReference type="DOI" id="10.1074/jbc.M112354200"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="35862" last="35868">
<title>Anti-apoptotic signaling of pleiotrophin through its receptor, anaplastic lymphoma kinase.</title>
<authorList>
<person name="Bowden E.T."/>
<person name="Stoica G.E."/>
<person name="Wellstein A."/>
</authorList>
<dbReference type="PubMed" id="12107166"/>
<dbReference type="DOI" id="10.1074/jbc.M203963200"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="35990" last="35998">
<title>Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types.</title>
<authorList>
<person name="Stoica G.E."/>
<person name="Kuo A."/>
<person name="Powers C."/>
<person name="Bowden E.T."/>
<person name="Sale E.B."/>
<person name="Riegel A.T."/>
<person name="Wellstein A."/>
</authorList>
<dbReference type="PubMed" id="12122009"/>
<dbReference type="DOI" id="10.1074/jbc.M205749200"/>
</citation>
<scope>INTERACTION WITH MDK</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2004" name="J. Cell Sci." volume="117" first="3319" last="3329">
<title>ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth.</title>
<authorList>
<person name="Motegi A."/>
<person name="Fujimoto J."/>
<person name="Kotani M."/>
<person name="Sakuraba H."/>
<person name="Yamamoto T."/>
</authorList>
<dbReference type="PubMed" id="15226403"/>
<dbReference type="DOI" id="10.1242/jcs.01183"/>
</citation>
<scope>INTERACTION WITH CBL; IRS1; PIK3R1; PLCG1 AND SHC1</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF CBL; IRS1 AND SHC1</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2005" name="Biochemistry" volume="44" first="8533" last="8542">
<title>Unique substrate specificity of anaplastic lymphoma kinase (ALK): development of phosphoacceptor peptides for the assay of ALK activity.</title>
<authorList>
<person name="Donella-Deana A."/>
<person name="Marin O."/>
<person name="Cesaro L."/>
<person name="Gunby R.H."/>
<person name="Ferrarese A."/>
<person name="Coluccia A.M."/>
<person name="Tartari C.J."/>
<person name="Mologni L."/>
<person name="Scapozza L."/>
<person name="Gambacorti-Passerini C."/>
<person name="Pinna L.A."/>
</authorList>
<dbReference type="PubMed" id="15938644"/>
<dbReference type="DOI" id="10.1021/bi0472954"/>
</citation>
<scope>SUBSTRATE SPECIFICITY</scope>
<scope>PHOSPHORYLATION AT TYR-1278</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="26953" last="26964">
<title>Differential induction of glioblastoma migration and growth by two forms of pleiotrophin.</title>
<authorList>
<person name="Lu K.V."/>
<person name="Jong K.A."/>
<person name="Kim G.Y."/>
<person name="Singh J."/>
<person name="Dia E.Q."/>
<person name="Yoshimoto K."/>
<person name="Wang M.Y."/>
<person name="Cloughesy T.F."/>
<person name="Nelson S.F."/>
<person name="Mischel P.S."/>
</authorList>
<dbReference type="PubMed" id="15908427"/>
<dbReference type="DOI" id="10.1074/jbc.M502614200"/>
</citation>
<scope>ROLE IN GLIOBLASTOMA</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2005" name="J. Cell Sci." volume="118" first="5811" last="5823">
<title>Role of the subcellular localization of ALK tyrosine kinase domain in neuronal differentiation of PC12 cells.</title>
<authorList>
<person name="Gouzi J.Y."/>
<person name="Moog-Lutz C."/>
<person name="Vigny M."/>
<person name="Brunet-de Carvalho N."/>
</authorList>
<dbReference type="PubMed" id="16317043"/>
<dbReference type="DOI" id="10.1242/jcs.02695"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>SUBUNIT</scope>
<scope>ENZYME REGULATION</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2005" name="Nat. Biotechnol." volume="23" first="94" last="101">
<title>Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.</title>
<authorList>
<person name="Rush J."/>
<person name="Moritz A."/>
<person name="Lee K.A."/>
<person name="Guo A."/>
<person name="Goss V.L."/>
<person name="Spek E.J."/>
<person name="Zhang H."/>
<person name="Zha X.-M."/>
<person name="Polakiewicz R.D."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="15592455"/>
<dbReference type="DOI" id="10.1038/nbt1046"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-1078; TYR-1096; TYR-1131 AND TYR-1604</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2006" name="Int. J. Cancer" volume="118" first="1181" last="1186">
<title>Fusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor.</title>
<authorList>
<person name="Panagopoulos I."/>
<person name="Nilsson T."/>
<person name="Domanski H.A."/>
<person name="Isaksson M."/>
<person name="Lindblom P."/>
<person name="Mertens F."/>
<person name="Mandahl N."/>
</authorList>
<dbReference type="PubMed" id="16161041"/>
<dbReference type="DOI" id="10.1002/ijc.21490"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH SEC31A</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2007" name="FEBS Lett." volume="581" first="727" last="734">
<title>ALK activation induces Shc and FRS2 recruitment: Signaling and phenotypic outcomes in PC12 cells differentiation.</title>
<authorList>
<person name="Degoutin J."/>
<person name="Vigny M."/>
<person name="Gouzi J.Y."/>
</authorList>
<dbReference type="PubMed" id="17274988"/>
<dbReference type="DOI" id="10.1016/j.febslet.2007.01.039"/>
</citation>
<scope>INTERACTION WITH FRS2 AND SHC1</scope>
<scope>PHOSPHORYLATION AT TYR-1507</scope>
<scope>MUTAGENESIS OF TYR-1507</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF FRS2; MAPK1/ERK2; MAPK3/ERK1 AND SHC1</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="28683" last="28690">
<title>Anaplastic lymphoma kinase is activated through the pleiotrophin/receptor protein-tyrosine phosphatase beta/zeta signaling pathway: an alternative mechanism of receptor tyrosine kinase activation.</title>
<authorList>
<person name="Perez-Pinera P."/>
<person name="Zhang W."/>
<person name="Chang Y."/>
<person name="Vega J.A."/>
<person name="Deuel T.F."/>
</authorList>
<dbReference type="PubMed" id="17681947"/>
<dbReference type="DOI" id="10.1074/jbc.M704505200"/>
</citation>
<scope>PHOSPHORYLATION</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2007" name="Oncogene" volume="26" first="859" last="869">
<title>Recruitment of insulin receptor substrate-1 and activation of NF-kappaB essential for midkine growth signaling through anaplastic lymphoma kinase.</title>
<authorList>
<person name="Kuo A.H."/>
<person name="Stoica G.E."/>
<person name="Riegel A.T."/>
<person name="Wellstein A."/>
</authorList>
<dbReference type="PubMed" id="16878150"/>
<dbReference type="DOI" id="10.1038/sj.onc.1209840"/>
</citation>
<scope>INTERACTION WITH IRS1 AND SHC</scope>
<scope>PHOSPHORYLATION AT TYR-1096</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2009" name="Biochem. J." volume="420" first="345" last="361">
<title>Anaplastic lymphoma kinase: signalling in development and disease.</title>
<authorList>
<person name="Palmer R.H."/>
<person name="Vernersson E."/>
<person name="Grabbe C."/>
<person name="Hallberg B."/>
</authorList>
<dbReference type="PubMed" id="19459784"/>
<dbReference type="DOI" id="10.1042/BJ20090387"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2012" name="Nat. Med." volume="18" first="382" last="384">
<title>Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies.</title>
<authorList>
<person name="Lipson D."/>
<person name="Capelletti M."/>
<person name="Yelensky R."/>
<person name="Otto G."/>
<person name="Parker A."/>
<person name="Jarosz M."/>
<person name="Curran J.A."/>
<person name="Balasubramanian S."/>
<person name="Bloom T."/>
<person name="Brennan K.W."/>
<person name="Donahue A."/>
<person name="Downing S.R."/>
<person name="Frampton G.M."/>
<person name="Garcia L."/>
<person name="Juhn F."/>
<person name="Mitchell K.C."/>
<person name="White E."/>
<person name="White J."/>
<person name="Zwirko Z."/>
<person name="Peretz T."/>
<person name="Nechushtan H."/>
<person name="Soussan-Gutman L."/>
<person name="Kim J."/>
<person name="Sasaki H."/>
<person name="Kim H.R."/>
<person name="Park S.I."/>
<person name="Ercan D."/>
<person name="Sheehan C.E."/>
<person name="Ross J.S."/>
<person name="Cronin M.T."/>
<person name="Jaenne P.A."/>
<person name="Stephens P.J."/>
</authorList>
<dbReference type="PubMed" id="22327622"/>
<dbReference type="DOI" id="10.1038/nm.2673"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH WDCP</scope>
</reference>
<reference key="25">
<citation type="submission" date="2008-04" db="PDB data bank">
<title>Solution structure of the complex of the PTB domain of SNT-2 and 19-residue peptide (aa 1571-1589) of HALK.</title>
<authorList>
<consortium name="RIKEN structural genomics initiative (RSGI)"/>
</authorList>
</citation>
<scope>STRUCTURE BY NMR OF 1571-1589</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2010" name="Biochem. J." volume="430" first="425" last="437">
<title>Crystal structure of the ALK (anaplastic lymphoma kinase) catalytic domain.</title>
<authorList>
<person name="Lee C.C."/>
<person name="Jia Y."/>
<person name="Li N."/>
<person name="Sun X."/>
<person name="Ng K."/>
<person name="Ambing E."/>
<person name="Gao M.Y."/>
<person name="Hua S."/>
<person name="Chen C."/>
<person name="Kim S."/>
<person name="Michellys P.Y."/>
<person name="Lesley S.A."/>
<person name="Harris J.L."/>
<person name="Spraggon G."/>
</authorList>
<dbReference type="PubMed" id="20632993"/>
<dbReference type="DOI" id="10.1042/BJ20100609"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 1072-1410</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2010" name="Biochemistry" volume="49" first="6813" last="6825">
<title>Crystal structures of anaplastic lymphoma kinase in complex with ATP competitive inhibitors.</title>
<authorList>
<person name="Bossi R.T."/>
<person name="Saccardo M.B."/>
<person name="Ardini E."/>
<person name="Menichincheri M."/>
<person name="Rusconi L."/>
<person name="Magnaghi P."/>
<person name="Orsini P."/>
<person name="Avanzi N."/>
<person name="Borgia A.L."/>
<person name="Nesi M."/>
<person name="Bandiera T."/>
<person name="Fogliatto G."/>
<person name="Bertrand J.A."/>
</authorList>
<dbReference type="PubMed" id="20695522"/>
<dbReference type="DOI" id="10.1021/bi1005514"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 1094-1407 IN COMPLEX WITH INHIBITOR</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2010" name="J. Struct. Funct. Genomics" volume="11" first="125" last="141">
<title>Structural basis for the recognition of nucleophosmin-anaplastic lymphoma kinase oncoprotein by the phosphotyrosine binding domain of Suc1-associated neurotrophic factor-induced tyrosine-phosphorylated target-2.</title>
<authorList>
<person name="Koshiba S."/>
<person name="Li H."/>
<person name="Motoda Y."/>
<person name="Tomizawa T."/>
<person name="Kasai T."/>
<person name="Tochio N."/>
<person name="Yabuki T."/>
<person name="Harada T."/>
<person name="Watanabe S."/>
<person name="Tanaka A."/>
<person name="Shirouzu M."/>
<person name="Kigawa T."/>
<person name="Yamamoto T."/>
<person name="Yokoyama S."/>
</authorList>
<dbReference type="PubMed" id="20454865"/>
<dbReference type="DOI" id="10.1007/s10969-010-9091-x"/>
</citation>
<scope>STRUCTURE BY NMR OF 1571-1589</scope>
</reference>
<reference key="29">
<citation type="submission" date="2011-05" db="PDB data bank">
<title>Structure of L1196M mutant anaplastic lymphoma kinase in complex with crizotinib.</title>
<authorList>
<person name="Mctigue M."/>
<person name="Deng Y."/>
<person name="Liu W."/>
<person name="Brooun A."/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF 1093-1411 IN COMPLEX WITH CRIZOTINIB</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2011" name="Cancer Cell" volume="19" first="679" last="690">
<title>CH5424802, a selective ALK inhibitor capable of blocking the resistant gatekeeper mutant.</title>
<authorList>
<person name="Sakamoto H."/>
<person name="Tsukaguchi T."/>
<person name="Hiroshima S."/>
<person name="Kodama T."/>
<person name="Kobayashi T."/>
<person name="Fukami T.A."/>
<person name="Oikawa N."/>
<person name="Tsukuda T."/>
<person name="Ishii N."/>
<person name="Aoki Y."/>
</authorList>
<dbReference type="PubMed" id="21575866"/>
<dbReference type="DOI" id="10.1016/j.ccr.2011.04.004"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 1069-1411 IN COMPLEX WITH INHIBITOR</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] LEU-90; LEU-163; GLN-296; ALA-476; PHE-560; ILE-680; THR-704; SER-877; MET-1012; ASP-1121; THR-1274; LEU-1328; ASN-1416; LYS-1419; ARG-1429; ARG-1491 AND GLU-1529</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2008" name="Nature" volume="455" first="930" last="935">
<title>Identification of ALK as a major familial neuroblastoma predisposition gene.</title>
<authorList>
<person name="Mosse Y.P."/>
<person name="Laudenslager M."/>
<person name="Longo L."/>
<person name="Cole K.A."/>
<person name="Wood A."/>
<person name="Attiyeh E.F."/>
<person name="Laquaglia M.J."/>
<person name="Sennett R."/>
<person name="Lynch J.E."/>
<person name="Perri P."/>
<person name="Laureys G."/>
<person name="Speleman F."/>
<person name="Kim C."/>
<person name="Hou C."/>
<person name="Hakonarson H."/>
<person name="Torkamani A."/>
<person name="Schork N.J."/>
<person name="Brodeur G.M."/>
<person name="Tonini G.P."/>
<person name="Rappaport E."/>
<person name="Devoto M."/>
<person name="Maris J.M."/>
</authorList>
<dbReference type="PubMed" id="18724359"/>
<dbReference type="DOI" id="10.1038/nature07261"/>
</citation>
<scope>VARIANTS NBLST3 ASN-1091; ALA-1128; ARG-1166; ASN-1171; ILE-1174; PRO-1192; CYS-1245; VAL-1245 THR-1250 AND GLN-1275</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2008" name="Nature" volume="455" first="967" last="970">
<title>Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma.</title>
<authorList>
<person name="Janoueix-Lerosey I."/>
<person name="Lequin D."/>
<person name="Brugieres L."/>
<person name="Ribeiro A."/>
<person name="de Pontual L."/>
<person name="Combaret V."/>
<person name="Raynal V."/>
<person name="Puisieux A."/>
<person name="Schleiermacher G."/>
<person name="Pierron G."/>
<person name="Valteau-Couanet D."/>
<person name="Frebourg T."/>
<person name="Michon J."/>
<person name="Lyonnet S."/>
<person name="Amiel J."/>
<person name="Delattre O."/>
</authorList>
<dbReference type="PubMed" id="18923523"/>
<dbReference type="DOI" id="10.1038/nature07398"/>
</citation>
<scope>VARIANTS NBLST3 VAL-1174; LEU-1174; CYS-1174; PRO-1192; GLN-1275 AND SER-1278</scope>
<scope>VARIANT LEU-1275</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2008" name="Nature" volume="455" first="975" last="978">
<title>Activating mutations in ALK provide a therapeutic target in neuroblastoma.</title>
<authorList>
<person name="George R.E."/>
<person name="Sanda T."/>
<person name="Hanna M."/>
<person name="Froehling S."/>
<person name="Luther W. II"/>
<person name="Zhang J."/>
<person name="Ahn Y."/>
<person name="Zhou W."/>
<person name="London W.B."/>
<person name="McGrady P."/>
<person name="Xue L."/>
<person name="Zozulya S."/>
<person name="Gregor V.E."/>
<person name="Webb T.R."/>
<person name="Gray N.S."/>
<person name="Gilliland D.G."/>
<person name="Diller L."/>
<person name="Greulich H."/>
<person name="Morris S.W."/>
<person name="Meyerson M."/>
<person name="Look A.T."/>
</authorList>
<dbReference type="PubMed" id="18923525"/>
<dbReference type="DOI" id="10.1038/nature07397"/>
</citation>
<scope>VARIANTS NBLST3 MET-1151; LEU-1174; THR-1234; CYS-1245 AND GLN-1275</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2011" name="Oncogene" volume="30" first="2017" last="2025">
<title>The constitutive activity of the ALK mutated at positions F1174 or R1275 impairs receptor trafficking.</title>
<authorList>
<person name="Mazot P."/>
<person name="Cazes A."/>
<person name="Boutterin M.C."/>
<person name="Figueiredo A."/>
<person name="Raynal V."/>
<person name="Combaret V."/>
<person name="Hallberg B."/>
<person name="Palmer R.H."/>
<person name="Delattre O."/>
<person name="Janoueix-Lerosey I."/>
<person name="Vigny M."/>
</authorList>
<dbReference type="PubMed" id="21242967"/>
<dbReference type="DOI" id="10.1038/onc.2010.595"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS NBLST3 LEU-1174; VAL-1174 AND GLN-1275</scope>
</reference>
<comment type="function">
<text evidence="16 17 18 19 20 21 22 23 25 26 27">Neuronal receptor tyrosine kinase that is essentially and transiently expressed in specific regions of the central and peripheral nervous systems and plays an important role in the genesis and differentiation of the nervous system. Transduces signals from ligands at the cell surface, through specific activation of the mitogen-activated protein kinase (MAPK) pathway. Phosphorylates almost exclusively at the first tyrosine of the Y-x-x-x-Y-Y motif. Following activation by ligand, ALK induces tyrosine phosphorylation of CBL, FRS2, IRS1 and SHC1, as well as of the MAP kinases MAPK1/ERK2 and MAPK3/ERK1. Acts as a receptor for ligands pleiotrophin (PTN), a secreted growth factor, and midkine (MDK), a PTN-related factor, thus participating in PTN and MDK signal transduction. PTN-binding induces MAPK pathway activation, which is important for the anti-apoptotic signaling of PTN and regulation of cell proliferation. MDK-binding induces phosphorylation of the ALK target insulin receptor substrate (IRS1), activates mitogen-activated protein kinases (MAPKs) and PI3-kinase, resulting also in cell proliferation induction. Drives NF-kappa-B activation, probably through IRS1 and the activation of the AKT serine/threonine kinase. Recruitment of IRS1 to activated ALK and the activation of NF-kappa-B are essential for the autocrine growth and survival signaling of MDK.</text>
</comment>
<comment type="catalytic activity">
<text evidence="15">ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="25 29 35">Activated by ligand-binding and subsequent phosphorylation. Inactivated through dephosphorylation by receptor protein tyrosine phosphatase beta and zeta complex (PTPRB/PTPRZ1) when there is no stimulation by a ligand. Staurosporine, crizotinib and CH5424802 act as inhibitors of ALK kinase activity.</text>
</comment>
<comment type="subunit">
<text evidence="10">Homodimer. Homodimerizes when bound to ligand. Interacts with FRS2, IRS1, MDK, PTN and SHC1. Interacts with CBL, PIK3R1 and PLCG1 (By similarity).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-357361"/>
<interactant intactId="EBI-357361"/>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-357361"/>
<interactant intactId="EBI-11691642">
<id>Q6UXT8</id>
<label>FAM150A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-357361"/>
<interactant intactId="EBI-11691780">
<id>Q6UX46</id>
<label>FAM150B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-357361"/>
<interactant intactId="EBI-352572">
<id>P08238</id>
<label>HSP90AB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-357361"/>
<interactant intactId="EBI-2263175">
<id>P23471</id>
<label>PTPRZ1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="25 39">Cell membrane</location>
<topology evidence="25 39">Single-pass type I membrane protein</topology>
</subcellularLocation>
<text>Membrane attachment was crucial for promotion of neuron-like differentiation and cell proliferation arrest through specific activation of the MAP kinase pathway.</text>
</comment>
<comment type="tissue specificity">
<text evidence="39">Expressed in brain and CNS. Also expressed in the small intestine and testis, but not in normal lymphoid cells.</text>
</comment>
<comment type="PTM">
<text evidence="16 24 26 27 29">Phosphorylated at tyrosine residues by autocatalysis, which activates kinase activity. In cells not stimulated by a ligand, receptor protein tyrosine phosphatase beta and zeta complex (PTPRB/PTPRZ1) dephosphorylates ALK at the sites in ALK that are undergoing autophosphorylation through autoactivation. Phosphorylation at Tyr-1507 is critical for SHC1 association.</text>
</comment>
<comment type="PTM">
<text evidence="39">N-glycosylated.</text>
</comment>
<comment type="disease">
<text>A chromosomal aberration involving ALK is found in a form of non-Hodgkin lymphoma. Translocation t(2;5)(p23;q35) with NPM1. The resulting chimeric NPM1-ALK protein homodimerize and the kinase becomes constitutively activated. The constitutively active fusion proteins are responsible for 5-10% of non-Hodgkin lymphomas.</text>
</comment>
<comment type="disease">
<text>A chromosomal aberration involving ALK is associated with inflammatory myofibroblastic tumors (IMTs). Translocation t(2;11)(p23;p15) with CARS; translocation t(2;4)(p23;q21) with SEC31A.</text>
</comment>
<comment type="disease">
<text>A chromosomal aberration involving ALK is associated with anaplastic large-cell lymphoma (ALCL). Translocation t(2;17)(p23;q25) with ALO17.</text>
</comment>
<comment type="disease" evidence="30 31 32 34">
<disease id="DI-02632">
<name>Neuroblastoma 3</name>
<acronym>NBLST3</acronym>
<description>A common neoplasm of early childhood arising from embryonic cells that form the primitive neural crest and give rise to the adrenal medulla and the sympathetic nervous system.</description>
<dbReference type="MIM" id="613014"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<text>The ALK signaling pathway plays an important role in glioblastoma, the most common malignant brain tumor of adults and one of the most lethal cancers. It regulates both glioblastoma migration and growth.</text>
</comment>
<comment type="disease">
<text evidence="36">A chromosomal aberration involving ALK is found in one subject with colorectal cancer. Translocation t(2;2)(p23.1;p23.3). A 5 million base pair tandem duplication generates an in-frame WDCP-ALK gene fusion.</text>
</comment>
<comment type="similarity">
<text evidence="14">Belongs to the protein kinase superfamily. Tyr protein kinase family. Insulin receptor subfamily.</text>
</comment>
<comment type="sequence caution" evidence="41">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAD92714" version="1"/>
</conflict>
<text>Translation N-terminally shortened.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/ALKID16.html"/>
</comment>
<dbReference type="EC" id="2.7.10.1"/>
<dbReference type="EMBL" id="U62540">
<property type="protein sequence ID" value="AAB71619.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U66559">
<property type="protein sequence ID" value="AAC51104.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB209477">
<property type="protein sequence ID" value="BAD92714.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC106870">
<property type="protein sequence ID" value="AAX93126.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC093756">
<property type="protein sequence ID" value="AAX88892.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC074096">
<property type="protein sequence ID" value="AAY15027.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS33172.1"/>
<dbReference type="RefSeq" id="NP_004295.2">
<property type="nucleotide sequence ID" value="NM_004304.4"/>
</dbReference>
<dbReference type="UniGene" id="Hs.654469"/>
<dbReference type="PDB" id="2KUP">
<property type="method" value="NMR"/>
<property type="chains" value="B=1571-1589"/>
</dbReference>
<dbReference type="PDB" id="2KUQ">
<property type="method" value="NMR"/>
<property type="chains" value="A=1571-1589"/>
</dbReference>
<dbReference type="PDB" id="2XB7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=1094-1407"/>
</dbReference>
<dbReference type="PDB" id="2XBA">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A=1094-1407"/>
</dbReference>
<dbReference type="PDB" id="2XP2">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=1093-1411"/>
</dbReference>
<dbReference type="PDB" id="2YFX">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=1093-1411"/>
</dbReference>
<dbReference type="PDB" id="2YHV">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=1093-1411"/>
</dbReference>
<dbReference type="PDB" id="2YJR">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=1093-1411"/>
</dbReference>
<dbReference type="PDB" id="2YJS">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=1093-1411"/>
</dbReference>
<dbReference type="PDB" id="2YS5">
<property type="method" value="NMR"/>
<property type="chains" value="B=1571-1589"/>
</dbReference>
<dbReference type="PDB" id="2YT2">
<property type="method" value="NMR"/>
<property type="chains" value="A=1571-1589"/>
</dbReference>
<dbReference type="PDB" id="3AOX">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.75"/>
<property type="chains" value="A=1069-1411"/>
</dbReference>
<dbReference type="PDB" id="3L9P">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=1072-1410"/>
</dbReference>
<dbReference type="PDB" id="3LCS">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A=1072-1410"/>
</dbReference>
<dbReference type="PDB" id="3LCT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=1072-1410"/>
</dbReference>
<dbReference type="PDB" id="4ANL">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=1093-1411"/>
</dbReference>
<dbReference type="PDB" id="4ANQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.76"/>
<property type="chains" value="A=1093-1411"/>
</dbReference>
<dbReference type="PDB" id="4ANS">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A=1093-1411"/>
</dbReference>
<dbReference type="PDB" id="4CCB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.03"/>
<property type="chains" value="A=1093-1411"/>
</dbReference>
<dbReference type="PDB" id="4CCU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=1093-1411"/>
</dbReference>
<dbReference type="PDB" id="4CD0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.23"/>
<property type="chains" value="A=1093-1411"/>
</dbReference>
<dbReference type="PDB" id="4CLI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.05"/>
<property type="chains" value="A=1093-1411"/>
</dbReference>
<dbReference type="PDB" id="4CLJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.66"/>
<property type="chains" value="A=1093-1411"/>
</dbReference>
<dbReference type="PDB" id="4CMO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.05"/>
<property type="chains" value="A=1093-1411"/>
</dbReference>
<dbReference type="PDB" id="4CMT">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.73"/>
<property type="chains" value="A=1093-1411"/>
</dbReference>
<dbReference type="PDB" id="4CMU">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=1093-1411"/>
</dbReference>
<dbReference type="PDB" id="4CNH">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A/B=1093-1411"/>
</dbReference>
<dbReference type="PDB" id="4CTB">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.79"/>
<property type="chains" value="A=1093-1411"/>
</dbReference>
<dbReference type="PDB" id="4CTC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.03"/>
<property type="chains" value="A=1093-1411"/>
</dbReference>
<dbReference type="PDB" id="4DCE">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.03"/>
<property type="chains" value="A/B=1078-1410"/>
</dbReference>
<dbReference type="PDB" id="4FNW">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.75"/>
<property type="chains" value="A=1084-1410"/>
</dbReference>
<dbReference type="PDB" id="4FNX">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=1084-1410"/>
</dbReference>
<dbReference type="PDB" id="4FNY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.45"/>
<property type="chains" value="A=1084-1410"/>
</dbReference>
<dbReference type="PDB" id="4FNZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=1084-1410"/>
</dbReference>
<dbReference type="PDB" id="4FOB">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=1058-1410"/>
</dbReference>
<dbReference type="PDB" id="4FOC">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=1058-1410"/>
</dbReference>
<dbReference type="PDB" id="4FOD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=1078-1410"/>
</dbReference>
<dbReference type="PDB" id="4JOA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=1072-1410"/>
</dbReference>
<dbReference type="PDB" id="4MKC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.01"/>
<property type="chains" value="A=1072-1410"/>
</dbReference>
<dbReference type="PDB" id="4TT7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=1095-1410"/>
</dbReference>
<dbReference type="PDB" id="4Z55">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.55"/>
<property type="chains" value="A=1072-1410"/>
</dbReference>
<dbReference type="PDB" id="5A9U">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A=1093-1411"/>
</dbReference>
<dbReference type="PDB" id="5AA8">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.86"/>
<property type="chains" value="A=1093-1411"/>
</dbReference>
<dbReference type="PDB" id="5AA9">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.93"/>
<property type="chains" value="A=1093-1411"/>
</dbReference>
<dbReference type="PDB" id="5AAA">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.73"/>
<property type="chains" value="A=1093-1411"/>
</dbReference>
<dbReference type="PDB" id="5AAB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=1093-1411"/>
</dbReference>
<dbReference type="PDB" id="5AAC">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=1093-1411"/>
</dbReference>
<dbReference type="PDB" id="5FTO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.22"/>
<property type="chains" value="A=1094-1407"/>
</dbReference>
<dbReference type="PDB" id="5FTQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=1094-1407"/>
</dbReference>
<dbReference type="PDB" id="5IMX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.12"/>
<property type="chains" value="A=1093-1411"/>
</dbReference>
<dbReference type="PDB" id="5IUG">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.93"/>
<property type="chains" value="A=1084-1410"/>
</dbReference>
<dbReference type="PDB" id="5IUH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=1084-1410"/>
</dbReference>
<dbReference type="PDB" id="5IUI">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.88"/>
<property type="chains" value="A=1084-1410"/>
</dbReference>
<dbReference type="PDB" id="5J7H">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.96"/>
<property type="chains" value="A=1093-1407"/>
</dbReference>
<dbReference type="PDB" id="5KZ0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=1093-1411"/>
</dbReference>
<dbReference type="PDBsum" id="2KUP"/>
<dbReference type="PDBsum" id="2KUQ"/>
<dbReference type="PDBsum" id="2XB7"/>
<dbReference type="PDBsum" id="2XBA"/>
<dbReference type="PDBsum" id="2XP2"/>
<dbReference type="PDBsum" id="2YFX"/>
<dbReference type="PDBsum" id="2YHV"/>
<dbReference type="PDBsum" id="2YJR"/>
<dbReference type="PDBsum" id="2YJS"/>
<dbReference type="PDBsum" id="2YS5"/>
<dbReference type="PDBsum" id="2YT2"/>
<dbReference type="PDBsum" id="3AOX"/>
<dbReference type="PDBsum" id="3L9P"/>
<dbReference type="PDBsum" id="3LCS"/>
<dbReference type="PDBsum" id="3LCT"/>
<dbReference type="PDBsum" id="4ANL"/>
<dbReference type="PDBsum" id="4ANQ"/>
<dbReference type="PDBsum" id="4ANS"/>
<dbReference type="PDBsum" id="4CCB"/>
<dbReference type="PDBsum" id="4CCU"/>
<dbReference type="PDBsum" id="4CD0"/>
<dbReference type="PDBsum" id="4CLI"/>
<dbReference type="PDBsum" id="4CLJ"/>
<dbReference type="PDBsum" id="4CMO"/>
<dbReference type="PDBsum" id="4CMT"/>
<dbReference type="PDBsum" id="4CMU"/>
<dbReference type="PDBsum" id="4CNH"/>
<dbReference type="PDBsum" id="4CTB"/>
<dbReference type="PDBsum" id="4CTC"/>
<dbReference type="PDBsum" id="4DCE"/>
<dbReference type="PDBsum" id="4FNW"/>
<dbReference type="PDBsum" id="4FNX"/>
<dbReference type="PDBsum" id="4FNY"/>
<dbReference type="PDBsum" id="4FNZ"/>
<dbReference type="PDBsum" id="4FOB"/>
<dbReference type="PDBsum" id="4FOC"/>
<dbReference type="PDBsum" id="4FOD"/>
<dbReference type="PDBsum" id="4JOA"/>
<dbReference type="PDBsum" id="4MKC"/>
<dbReference type="PDBsum" id="4TT7"/>
<dbReference type="PDBsum" id="4Z55"/>
<dbReference type="PDBsum" id="5A9U"/>
<dbReference type="PDBsum" id="5AA8"/>
<dbReference type="PDBsum" id="5AA9"/>
<dbReference type="PDBsum" id="5AAA"/>
<dbReference type="PDBsum" id="5AAB"/>
<dbReference type="PDBsum" id="5AAC"/>
<dbReference type="PDBsum" id="5FTO"/>
<dbReference type="PDBsum" id="5FTQ"/>
<dbReference type="PDBsum" id="5IMX"/>
<dbReference type="PDBsum" id="5IUG"/>
<dbReference type="PDBsum" id="5IUH"/>
<dbReference type="PDBsum" id="5IUI"/>
<dbReference type="PDBsum" id="5J7H"/>
<dbReference type="PDBsum" id="5KZ0"/>
<dbReference type="ProteinModelPortal" id="Q9UM73"/>
<dbReference type="SMR" id="Q9UM73"/>
<dbReference type="BioGrid" id="106739">
<property type="interactions" value="62"/>
</dbReference>
<dbReference type="DIP" id="DIP-5954N"/>
<dbReference type="IntAct" id="Q9UM73">
<property type="interactions" value="10"/>
</dbReference>
<dbReference type="MINT" id="MINT-1133857"/>
<dbReference type="STRING" id="9606.ENSP00000373700"/>
<dbReference type="BindingDB" id="Q9UM73"/>
<dbReference type="ChEMBL" id="CHEMBL4247"/>
<dbReference type="DrugBank" id="DB00171">
<property type="generic name" value="Adenosine triphosphate"/>
</dbReference>
<dbReference type="DrugBank" id="DB11363">
<property type="generic name" value="Alectinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB09063">
<property type="generic name" value="Ceritinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB08865">
<property type="generic name" value="Crizotinib"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="1839"/>
<dbReference type="iPTMnet" id="Q9UM73"/>
<dbReference type="PhosphoSitePlus" id="Q9UM73"/>
<dbReference type="BioMuta" id="ALK"/>
<dbReference type="DMDM" id="296439447"/>
<dbReference type="PaxDb" id="Q9UM73"/>
<dbReference type="PeptideAtlas" id="Q9UM73"/>
<dbReference type="PRIDE" id="Q9UM73"/>
<dbReference type="DNASU" id="238"/>
<dbReference type="Ensembl" id="ENST00000389048">
<property type="protein sequence ID" value="ENSP00000373700"/>
<property type="gene ID" value="ENSG00000171094"/>
</dbReference>
<dbReference type="GeneID" id="238"/>
<dbReference type="KEGG" id="hsa:238"/>
<dbReference type="UCSC" id="uc002rmy.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="238"/>
<dbReference type="DisGeNET" id="238"/>
<dbReference type="GeneCards" id="ALK"/>
<dbReference type="GeneReviews" id="ALK"/>
<dbReference type="H-InvDB" id="HIX0024259"/>
<dbReference type="H-InvDB" id="HIX0030037"/>
<dbReference type="HGNC" id="HGNC:427">
<property type="gene designation" value="ALK"/>
</dbReference>
<dbReference type="HPA" id="HPA010694"/>
<dbReference type="MalaCards" id="ALK"/>
<dbReference type="MIM" id="105590">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="613014">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9UM73"/>
<dbReference type="OpenTargets" id="ENSG00000171094"/>
<dbReference type="Orphanet" id="300895">
<property type="disease" value="ALK-positive anaplastic large cell lymphoma"/>
</dbReference>
<dbReference type="Orphanet" id="364043">
<property type="disease" value="ALK-positive large B-cell lymphoma"/>
</dbReference>
<dbReference type="Orphanet" id="178342">
<property type="disease" value="Inflammatory myofibroblastic tumor"/>
</dbReference>
<dbReference type="Orphanet" id="635">
<property type="disease" value="Neuroblastoma"/>
</dbReference>
<dbReference type="Orphanet" id="357191">
<property type="disease" value="Selection of therapeutic option in non-small cell lung carcinoma"/>
</dbReference>
<dbReference type="PharmGKB" id="PA24719"/>
<dbReference type="eggNOG" id="KOG1095">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XPVX">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000118818"/>
<dbReference type="HOGENOM" id="HOG000231766"/>
<dbReference type="HOVERGEN" id="HBG018726"/>
<dbReference type="InParanoid" id="Q9UM73"/>
<dbReference type="KO" id="K05119"/>
<dbReference type="OMA" id="NAIMLSK"/>
<dbReference type="OrthoDB" id="EOG091G003T"/>
<dbReference type="PhylomeDB" id="Q9UM73"/>
<dbReference type="TreeFam" id="TF351636"/>
<dbReference type="BRENDA" id="2.7.10.1">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="SignaLink" id="Q9UM73"/>
<dbReference type="SIGNOR" id="Q9UM73"/>
<dbReference type="ChiTaRS" id="ALK">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q9UM73"/>
<dbReference type="GeneWiki" id="Anaplastic_lymphoma_kinase"/>
<dbReference type="GenomeRNAi" id="238"/>
<dbReference type="PRO" id="PR:Q9UM73"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 2"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000171094"/>
<dbReference type="CleanEx" id="HS_ALK"/>
<dbReference type="ExpressionAtlas" id="Q9UM73">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q9UM73">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005622">
<property type="term" value="C:intracellular"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="GOC"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0043234">
<property type="term" value="C:protein complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0004704">
<property type="term" value="F:NF-kappaB-inducing kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004713">
<property type="term" value="F:protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0004714">
<property type="term" value="F:transmembrane receptor protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000187">
<property type="term" value="P:activation of MAPK activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030534">
<property type="term" value="P:adult behavior"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008283">
<property type="term" value="P:cell proliferation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0021766">
<property type="term" value="P:hippocampus development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048666">
<property type="term" value="P:neuron development"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016310">
<property type="term" value="P:phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042981">
<property type="term" value="P:regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042127">
<property type="term" value="P:regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060159">
<property type="term" value="P:regulation of dopamine receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0090648">
<property type="term" value="P:response to environmental enrichment"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0036269">
<property type="term" value="P:swimming behavior"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007169">
<property type="term" value="P:transmembrane receptor protein tyrosine kinase signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="CDD" id="cd06263">
<property type="entry name" value="MAM"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="InterPro" id="IPR026830">
<property type="entry name" value="ALK"/>
</dbReference>
<dbReference type="InterPro" id="IPR013320">
<property type="entry name" value="ConA-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR002172">
<property type="entry name" value="LDrepeatLR_classA_rpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR000998">
<property type="entry name" value="MAM_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008266">
<property type="entry name" value="Tyr_kinase_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR020635">
<property type="entry name" value="Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR002011">
<property type="entry name" value="Tyr_kinase_rcpt_2_CS"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24416:SF388">
<property type="entry name" value="PTHR24416:SF388"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00629">
<property type="entry name" value="MAM"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="Pkinase_Tyr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00109">
<property type="entry name" value="TYRKINASE"/>
</dbReference>
<dbReference type="SMART" id="SM00192">
<property type="entry name" value="LDLa"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00219">
<property type="entry name" value="TyrKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49899">
<property type="entry name" value="SSF49899"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF57424">
<property type="entry name" value="SSF57424"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50060">
<property type="entry name" value="MAM_2"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00109">
<property type="entry name" value="PROTEIN_KINASE_TYR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00239">
<property type="entry name" value="RECEPTOR_TYR_KIN_II"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0160">Chromosomal rearrangement</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0829">Tyrosine-protein kinase</keyword>
<feature type="signal peptide" evidence="12">
<location>
<begin position="1"/>
<end position="18"/>
</location>
</feature>
<feature type="chain" description="ALK tyrosine kinase receptor" id="PRO_0000016740">
<location>
<begin position="19"/>
<end position="1620"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="12">
<location>
<begin position="19"/>
<end position="1038"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="12">
<location>
<begin position="1039"/>
<end position="1059"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="12">
<location>
<begin position="1060"/>
<end position="1620"/>
</location>
</feature>
<feature type="domain" description="MAM 1" evidence="13">
<location>
<begin position="264"/>
<end position="427"/>
</location>
</feature>
<feature type="domain" description="LDL-receptor class A">
<location>
<begin position="437"/>
<end position="473"/>
</location>
</feature>
<feature type="domain" description="MAM 2" evidence="13">
<location>
<begin position="478"/>
<end position="636"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="14">
<location>
<begin position="1116"/>
<end position="1392"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP">
<location>
<begin position="1197"/>
<end position="1199"/>
</location>
</feature>
<feature type="region of interest" description="Inhibitor binding">
<location>
<begin position="1197"/>
<end position="1199"/>
</location>
</feature>
<feature type="compositionally biased region" description="Gly-rich">
<location>
<begin position="816"/>
<end position="940"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="14 15">
<location>
<position position="1249"/>
</location>
</feature>
<feature type="binding site" description="ATP; via carbonyl oxygen">
<location>
<position position="1124"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="14">
<location>
<position position="1150"/>
</location>
</feature>
<feature type="binding site" description="Inhibitor" evidence="33 35">
<location>
<position position="1150"/>
</location>
</feature>
<feature type="binding site" description="Inhibitor; via amide nitrogen" evidence="33 35">
<location>
<position position="1199"/>
</location>
</feature>
<feature type="binding site" description="Inhibitor" evidence="33 35">
<location>
<position position="1203"/>
</location>
</feature>
<feature type="binding site" description="Inhibitor" evidence="33 35">
<location>
<position position="1210"/>
</location>
</feature>
<feature type="binding site" description="ATP">
<location>
<position position="1270"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="9">
<location>
<position position="1078"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="11">
<location>
<position position="1092"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="9 26">
<location>
<position position="1096"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="9">
<location>
<position position="1131"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="24">
<location>
<position position="1278"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="27">
<location>
<position position="1507"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="9">
<location>
<position position="1604"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12">
<location>
<position position="169"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12">
<location>
<position position="244"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12">
<location>
<position position="285"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12">
<location>
<position position="324"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12">
<location>
<position position="411"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12">
<location>
<position position="424"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12">
<location>
<position position="445"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12">
<location>
<position position="563"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12">
<location>
<position position="571"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12">
<location>
<position position="627"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12">
<location>
<position position="709"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12">
<location>
<position position="808"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12">
<location>
<position position="863"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12">
<location>
<position position="864"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12">
<location>
<position position="886"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12">
<location>
<position position="986"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34617074." id="VAR_041477" evidence="28">
<original>S</original>
<variation>L</variation>
<location>
<position position="90"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55697431." id="VAR_041478" evidence="28">
<original>V</original>
<variation>L</variation>
<location>
<position position="163"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56077855." id="VAR_041479" evidence="28">
<original>E</original>
<variation>Q</variation>
<location>
<position position="296"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35093491." id="VAR_041480" evidence="28">
<original>V</original>
<variation>A</variation>
<location>
<position position="476"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast pleomorphic lobular carcinoma sample; somatic mutation." id="VAR_041481" evidence="28">
<original>L</original>
<variation>F</variation>
<location>
<position position="560"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35228363." id="VAR_041482" evidence="28">
<original>T</original>
<variation>I</variation>
<location>
<position position="680"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34829159." id="VAR_041483" evidence="28">
<original>A</original>
<variation>T</variation>
<location>
<position position="704"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55941323." id="VAR_061288">
<original>L</original>
<variation>Q</variation>
<location>
<position position="868"/>
</location>
</feature>
<feature type="sequence variant" description="In an ovarian serous carcinoma sample; somatic mutation; dbSNP:rs746442213." id="VAR_041484" evidence="28">
<original>A</original>
<variation>S</variation>
<location>
<position position="877"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35073634." id="VAR_041485" evidence="28">
<original>T</original>
<variation>M</variation>
<location>
<position position="1012"/>
</location>
</feature>
<feature type="sequence variant" description="In NBLST3; somatic mutation; dbSNP:rs864309584." id="VAR_063850" evidence="30">
<original>D</original>
<variation>N</variation>
<location>
<position position="1091"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55760835." id="VAR_041486" evidence="28">
<original>G</original>
<variation>D</variation>
<location>
<position position="1121"/>
</location>
</feature>
<feature type="sequence variant" description="In NBLST3; dbSNP:rs113994088." id="VAR_063851" evidence="30">
<original>G</original>
<variation>A</variation>
<location>
<position position="1128"/>
</location>
</feature>
<feature type="sequence variant" description="In NBLST3; dbSNP:rs113994091." id="VAR_063852" evidence="32">
<original>T</original>
<variation>M</variation>
<location>
<position position="1151"/>
</location>
</feature>
<feature type="sequence variant" description="In NBLST3; somatic mutation." id="VAR_063853" evidence="30">
<original>M</original>
<variation>R</variation>
<location>
<position position="1166"/>
</location>
</feature>
<feature type="sequence variant" description="In NBLST3; somatic mutation." id="VAR_063854" evidence="30">
<original>I</original>
<variation>N</variation>
<location>
<position position="1171"/>
</location>
</feature>
<feature type="sequence variant" description="In NBLST3." id="VAR_063855" evidence="31">
<original>F</original>
<variation>C</variation>
<location>
<position position="1174"/>
</location>
</feature>
<feature type="sequence variant" description="In NBLST3; somatic mutation." id="VAR_063856" evidence="30">
<original>F</original>
<variation>I</variation>
<location>
<position position="1174"/>
</location>
</feature>
<feature type="sequence variant" description="In NBLST3; somatic mutation; constitutively activated; retained in the endoplasmic reticulum and Golgi compartments; dbSNP:rs863225281." id="VAR_063857" evidence="31 32 34">
<original>F</original>
<variation>L</variation>
<location>
<position position="1174"/>
</location>
</feature>
<feature type="sequence variant" description="In NBLST3; somatic mutation; constitutively activated; retained in the endoplasmic reticulum and Golgi compartments; dbSNP:rs281864719." id="VAR_063858" evidence="31 34">
<original>F</original>
<variation>V</variation>
<location>
<position position="1174"/>
</location>
</feature>
<feature type="sequence variant" description="In NBLST3; dbSNP:rs113994089." id="VAR_063859" evidence="30 31">
<original>R</original>
<variation>P</variation>
<location>
<position position="1192"/>
</location>
</feature>
<feature type="sequence variant" description="In NBLST3; somatic mutation." id="VAR_063860" evidence="32">
<original>A</original>
<variation>T</variation>
<location>
<position position="1234"/>
</location>
</feature>
<feature type="sequence variant" description="In NBLST3; somatic mutation; dbSNP:rs863225283." id="VAR_063861" evidence="30 32">
<original>F</original>
<variation>C</variation>
<location>
<position position="1245"/>
</location>
</feature>
<feature type="sequence variant" description="In NBLST3; somatic mutation; dbSNP:rs281864720." id="VAR_063862">
<original>F</original>
<variation>V</variation>
<location>
<position position="1245"/>
</location>
</feature>
<feature type="sequence variant" description="In NBLST3; somatic mutation; dbSNP:rs113994092." id="VAR_063863" evidence="30">
<original>I</original>
<variation>T</variation>
<location>
<position position="1250"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs45502292." id="VAR_041487" evidence="28">
<original>A</original>
<variation>T</variation>
<location>
<position position="1274"/>
</location>
</feature>
<feature type="sequence variant" description="Observed in neuroblastoma." id="VAR_063864" evidence="31">
<original>R</original>
<variation>L</variation>
<location>
<position position="1275"/>
</location>
</feature>
<feature type="sequence variant" description="In NBLST3; constitutively activated; retained in the endoplasmic reticulum and Golgi compartments; dbSNP:rs113994087." id="VAR_063865" evidence="30 31 32 34">
<original>R</original>
<variation>Q</variation>
<location>
<position position="1275"/>
</location>
</feature>
<feature type="sequence variant" description="In NBLST3; somatic mutation; dbSNP:rs863225285." id="VAR_063866" evidence="31">
<original>Y</original>
<variation>S</variation>
<location>
<position position="1278"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56160491." id="VAR_041488" evidence="28">
<original>M</original>
<variation>L</variation>
<location>
<position position="1328"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17694720." id="VAR_055987">
<original>F</original>
<variation>S</variation>
<location>
<position position="1376"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55782189." id="VAR_041489" evidence="28">
<original>K</original>
<variation>N</variation>
<location>
<position position="1416"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56181542." id="VAR_041490" evidence="28">
<original>E</original>
<variation>K</variation>
<location>
<position position="1419"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55906201." id="VAR_041491" evidence="28">
<original>Q</original>
<variation>R</variation>
<location>
<position position="1429"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1670283." id="VAR_031042" evidence="37 38 39 40">
<original>I</original>
<variation>V</variation>
<location>
<position position="1461"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1881420." id="VAR_031043" evidence="28 38 40">
<original>K</original>
<variation>R</variation>
<location>
<position position="1491"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1881421." id="VAR_031044" evidence="28 38 40">
<original>D</original>
<variation>E</variation>
<location>
<position position="1529"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1881423." id="VAR_055988">
<original>P</original>
<variation>H</variation>
<location>
<position position="1599"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs interaction with SHC1." evidence="27">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1507"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAB71619." ref="1" evidence="41">
<original>P</original>
<variation>S</variation>
<location>
<position position="36"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1087"/>
<end position="1092"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="1096"/>
<end position="1098"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="1101"/>
<end position="1103"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="1105"/>
<end position="1107"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="1113"/>
<end position="1115"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="1116"/>
<end position="1124"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="1126"/>
<end position="1135"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="1137"/>
<end position="1140"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="1145"/>
<end position="1152"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="1154"/>
<end position="1156"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="1158"/>
<end position="1173"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="1182"/>
<end position="1186"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="1188"/>
<end position="1197"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="1204"/>
<end position="1211"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="1215"/>
<end position="1217"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="1223"/>
<end position="1242"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="1252"/>
<end position="1254"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="1255"/>
<end position="1258"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="1260"/>
<end position="1263"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="1266"/>
<end position="1268"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="1272"/>
<end position="1280"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="1288"/>
<end position="1290"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="1293"/>
<end position="1295"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="1298"/>
<end position="1303"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="1308"/>
<end position="1323"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="1335"/>
<end position="1343"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="1356"/>
<end position="1365"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="1370"/>
<end position="1372"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="1376"/>
<end position="1388"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="1390"/>
<end position="1393"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1574"/>
<end position="1576"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1582"/>
<end position="1584"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2KUP"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2YT2"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3AOX"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3LCS"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4DCE"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4Z55"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5A9U"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5IUI"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="15592455"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000250"/>
<evidence key="11" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P97793"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000255"/>
<evidence key="13" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00128"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10028"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11121404"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11278720"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11387242"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11809760"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12107166"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12122009"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15226403"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15908427"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15938644"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16317043"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16878150"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17274988"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17681947"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18724359"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18923523"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18923525"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20695522"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21242967"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21575866"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22327622"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8122112"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9053841"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9174053"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source ref="4"/>
</evidence>
<evidence key="41" type="ECO:0000305"/>
<sequence length="1620" mass="176442" checksum="0733D6C4FD212F41" modified="2010-05-18" version="3" precursor="true">
MGAIGLLWLLPLLLSTAAVGSGMGTGQRAGSPAAGPPLQPREPLSYSRLQRKSLAVDFVV
PSLFRVYARDLLLPPSSSELKAGRPEARGSLALDCAPLLRLLGPAPGVSWTAGSPAPAEA
RTLSRVLKGGSVRKLRRAKQLVLELGEEAILEGCVGPPGEAAVGLLQFNLSELFSWWIRQ
GEGRLRIRLMPEKKASEVGREGRLSAAIRASQPRLLFQIFGTGHSSLESPTNMPSPSPDY
FTWNLTWIMKDSFPFLSHRSRYGLECSFDFPCELEYSPPLHDLRNQSWSWRRIPSEEASQ
MDLLDGPGAERSKEMPRGSFLLLNTSADSKHTILSPWMRSSSEHCTLAVSVHRHLQPSGR
YIAQLLPHNEAAREILLMPTPGKHGWTVLQGRIGRPDNPFRVALEYISSGNRSLSAVDFF
ALKNCSEGTSPGSKMALQSSFTCWNGTVLQLGQACDFHQDCAQGEDESQMCRKLPVGFYC
NFEDGFCGWTQGTLSPHTPQWQVRTLKDARFQDHQDHALLLSTTDVPASESATVTSATFP
APIKSSPCELRMSWLIRGVLRGNVSLVLVENKTGKEQGRMVWHVAAYEGLSLWQWMVLPL
LDVSDRFWLQMVAWWGQGSRAIVAFDNISISLDCYLTISGEDKILQNTAPKSRNLFERNP
NKELKPGENSPRQTPIFDPTVHWLFTTCGASGPHGPTQAQCNNAYQNSNLSVEVGSEGPL
KGIQIWKVPATDTYSISGYGAAGGKGGKNTMMRSHGVSVLGIFNLEKDDMLYILVGQQGE
DACPSTNQLIQKVCIGENNVIEEEIRVNRSVHEWAGGGGGGGGATYVFKMKDGVPVPLII
AAGGGGRAYGAKTDTFHPERLENNSSVLGLNGNSGAAGGGGGWNDNTSLLWAGKSLQEGA
TGGHSCPQAMKKWGWETRGGFGGGGGGCSSGGGGGGYIGGNAASNNDPEMDGEDGVSFIS
PLGILYTPALKVMEGHGEVNIKHYLNCSHCEVDECHMDPESHKVICFCDHGTVLAEDGVS
CIVSPTPEPHLPLSLILSVVTSALVAALVLAFSGIMIVYRRKHQELQAMQMELQSPEYKL
SKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPN
DPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMA
GGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCP
GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLW
EIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL
ERIEYCTQDPDVINTALPIEYGPLVEEEEKVPVRPKDPEGVPPLLVSQQAKREEERSPAA
PPPLPTTSSGKAAKKPTAAEISVRVPRGPAVEGGHVNMAFSQSNPPSELHKVHGSRNKPT
SLWNPTYGSWFTEKPTKKNNPIAKKEPHDRGNLGLEGSCTVPPNVATGRLPGASLLLEPS
SLTANMKEVPLFRLRHFPCGNVNYGYQQQGLPLEAATAPGAGHYEDTILKSKNSMNQPGP
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>